# Chapter 48 7348809A Radioactive Drug Research Committee - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/program/chapter-48-7348809a-radioactive-drug-research-committee/bfb941da-2647-409d-bbc4-1bdb2311eaf4

> FDA guidance document: Chapter 48 7348809A Radioactive Drug Research Committee. Issue date: April 16, 2018. Get complete insights and analysis.

---

## Details

- Title: Chapter 48 7348809A Radioactive Drug Research Committee
- Communication Type: Program
- Product Type: other
- Office Name: Office of Regulatory Affairs
- Office URL: /offices/office-of-regulatory-affairs/ff91c598-cf72-4dbe-a2c8-7519c64cbc64
- Issue Date: 2018-04-16
- Last Changed: 2018-12-01

## Related Documents

- [CDER CDRH Combo Product Compliance Program](https://www.globalkeysolutions.net/guidances/program/cder-cdrh-combo-product-compliance-program/a40457d2-e1b2-4a3c-83ab-8aecd8da0221)
- [CHAPTER 48 - 7348809 Bioresearch Monitoring](https://www.globalkeysolutions.net/guidances/program/chapter-48-7348809-bioresearch-monitoring/32cb56f9-118b-4f48-b9f0-9376f28a15d0)
- [Final In Vivo Bioavailability-Bioequivalence Studies- Analytical](https://www.globalkeysolutions.net/guidances/guidance-document/final-in-vivo-bioavailability-bioequivalence-studies-analytical/79269a54-7602-4765-bb0d-fc1bb25d6c42)